[go: up one dir, main page]

WO2006016020A3 - Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan - Google Patents

Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan Download PDF

Info

Publication number
WO2006016020A3
WO2006016020A3 PCT/FR2005/001398 FR2005001398W WO2006016020A3 WO 2006016020 A3 WO2006016020 A3 WO 2006016020A3 FR 2005001398 W FR2005001398 W FR 2005001398W WO 2006016020 A3 WO2006016020 A3 WO 2006016020A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymer
nanoparticles
active principle
bisulfan
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2005/001398
Other languages
English (en)
Other versions
WO2006016020A2 (fr
Inventor
Anne Magali Layre
Ruxandra Gref
Patrick Couvreur
Joel Richard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Publication of WO2006016020A2 publication Critical patent/WO2006016020A2/fr
Publication of WO2006016020A3 publication Critical patent/WO2006016020A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention se rapporte à des nanoparticules polymériques composites biodégradables, pouvant contenir éventuellement un principe actif, ainsi qu'à des suspensions en milieu aqueux de telles particules, leur préparation et leur utilisation.
PCT/FR2005/001398 2004-07-07 2005-06-07 Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan Ceased WO2006016020A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0407569A FR2872703B1 (fr) 2004-07-07 2004-07-07 Nanoparticules polymeriques composites
FR0407569 2004-07-07

Publications (2)

Publication Number Publication Date
WO2006016020A2 WO2006016020A2 (fr) 2006-02-16
WO2006016020A3 true WO2006016020A3 (fr) 2006-07-13

Family

ID=34946547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2005/001398 Ceased WO2006016020A2 (fr) 2004-07-07 2005-06-07 Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan

Country Status (2)

Country Link
FR (1) FR2872703B1 (fr)
WO (1) WO2006016020A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008121077A1 (fr) * 2007-03-30 2008-10-09 Agency For Science, Technology And Research Point quantique encapsulé
DK3238709T3 (da) 2011-04-28 2020-09-28 Platform Brightworks Two Ltd Forbedrede parenterale formuleringer af lipofile farmaceutiske midler og fremgangsmåder til fremstilling og anvendelse af samme
CA2913328C (fr) 2013-05-28 2021-08-24 Sintef Tto As Procede de preparation de nanoparticules furtives
CN108453927A (zh) * 2018-02-08 2018-08-28 西安交通大学 一种可生物降解PCL/Mg复合材料FDM耗材的制备工艺
EP3773471A1 (fr) * 2018-03-27 2021-02-17 Sintef Tto As Nanoparticules de poly (cyanoacrylate d'alkyle) destinées à être utilisées dans le traitement du cancer
US12433846B2 (en) 2019-03-27 2025-10-07 Sintef Tto As Drug delivery system for treatment of cancer

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007895A1 (fr) * 1978-07-19 1980-02-06 Patrick Couvreur Nanoparticules biodégradables, compositions pharmaceutiques les contenant et procédé pour leur préparation
FR2608942A1 (fr) * 1986-12-31 1988-07-01 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
EP0447318A1 (fr) * 1990-03-16 1991-09-18 L'oreal Composition pour le traitement cosmétique et/ou pharmaceutique des couches supérieures de l'épiderme par application topique sur la peau et procédé de préparation correspondant
WO1996031231A1 (fr) * 1995-04-04 1996-10-10 Elan Corporation, Plc Nanoparticules biodegradables a liberation lente renfermant de l'insuline
WO1999043359A1 (fr) * 1998-02-27 1999-09-02 Bioalliance Pharma (S.A.) Nanoparticules comprenant polyisobutylcyanoacrylate et cyclodextrines
WO2003017987A1 (fr) * 2001-08-31 2003-03-06 Mcgill University Nanocapsules polymeres biodegradables et utilisation de celles-ci
CN1417242A (zh) * 2002-11-14 2003-05-14 天津大学 聚乙二醇接枝修饰的聚氰基丙烯酸酯共聚物及其制备方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0007895A1 (fr) * 1978-07-19 1980-02-06 Patrick Couvreur Nanoparticules biodégradables, compositions pharmaceutiques les contenant et procédé pour leur préparation
FR2608942A1 (fr) * 1986-12-31 1988-07-01 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
EP0447318A1 (fr) * 1990-03-16 1991-09-18 L'oreal Composition pour le traitement cosmétique et/ou pharmaceutique des couches supérieures de l'épiderme par application topique sur la peau et procédé de préparation correspondant
WO1996031231A1 (fr) * 1995-04-04 1996-10-10 Elan Corporation, Plc Nanoparticules biodegradables a liberation lente renfermant de l'insuline
WO1999043359A1 (fr) * 1998-02-27 1999-09-02 Bioalliance Pharma (S.A.) Nanoparticules comprenant polyisobutylcyanoacrylate et cyclodextrines
WO2003017987A1 (fr) * 2001-08-31 2003-03-06 Mcgill University Nanocapsules polymeres biodegradables et utilisation de celles-ci
CN1417242A (zh) * 2002-11-14 2003-05-14 天津大学 聚乙二醇接枝修饰的聚氰基丙烯酸酯共聚物及其制备方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 200370, Derwent World Patents Index; Class A14, AN 2003-732339, XP002317291 *
HASSAN M ET AL: "A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem transplantation: 500 mg/m<2> as a optimal total dose for conditioning", BONE MARROW TRANSPLANTATION 2002 UNITED KINGDOM, vol. 30, no. 12, 2002, pages 833 - 841, XP002367646, ISSN: 0268-3369 *

Also Published As

Publication number Publication date
FR2872703B1 (fr) 2006-10-06
FR2872703A1 (fr) 2006-01-13
WO2006016020A2 (fr) 2006-02-16

Similar Documents

Publication Publication Date Title
WO2007062266A3 (fr) Formes galeniques de ganaxolone et procedes de preparation et d&#39;utilisation de celles-ci
MX2009014115A (es) Microesferas que tienen estructura de nucleo/corteza.
WO2010077628A3 (fr) Composition d&#39;hygiène personnelle sous la forme d&#39;un article à structure solide soluble et poreuse
WO2005118128A8 (fr) Embolisation
EP2305787A3 (fr) Compositions comprenant des particules de délivrance contenant un agent bénéfique
EP4360756A3 (fr) Matières actives de batterie nanostructurées et leurs procédés de production
PL1879936T3 (pl) Wodne, stabilne podczas przechowywania emulsje polimerów zakończonych alfa-sililem, ich wytwarzanie i zastosowanie
WO2008007290A3 (fr) nanoparticules à noyau/enveloppe à des fins de thérapie et d&#39;imagerie
WO2005084637A3 (fr) Nouveaux procedes et nouvelle composition d&#39;administration de macromolecules par voie orale
IL190775A (en) Influenza virus-like particles, vaccines containing them and their uses
AU2002330851A1 (en) Functionalized fullerenes, their method of manufacture and uses thereof
AU2002361032A1 (en) Nanoscale core/shell particles and the production thereof
JP2011016732A5 (fr)
WO2007047498A3 (fr) Formation et encapsulation de membranes moleculaires monocouches et bicouches
WO2007076990A3 (fr) Particules d&#39;agglomerat, procede de production de nanocomposites et leur utilisation
WO2010002613A3 (fr) Procédé de fabrication d’une composition pharmaceutique en poudre sèche
WO2005094156A3 (fr) Oxydes metalliques a modification de surface, procedes de production desdits oxydes metalliques et leur utilisation dans des preparations cosmetiques
EP1640811A3 (fr) Révélateur
WO2005089297A3 (fr) Coussin a geometrie variable a auto ventilation et a auto refroidissement
WO2006016020A3 (fr) Nanoparticules comprenant un coeur constitue essentiellement d’un polymere cyanoacrylique et une ecorce d’un polymere amphiphile, et eventuellement un principe actif qui est preferablement du busulfan
WO2005073127A3 (fr) Procede de dissolution de nanotubes de carbone et ses applications
WO2006032655A3 (fr) Materiau ignifuge contenant un aerogel
WO2007086967A3 (fr) Compositions de particules fines et procédés associés
WO2008073731A3 (fr) Formes galéniques de microémulsion de valsartan et procédés de préparation de celles-ci
WO2007120193A3 (fr) Nanobiomatieres et leur synthese

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application